NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients

NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients

Abstract Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is useful to predict adverse outcomes. Change in NT-proBNP level may provide additional actionable risk assessment information. This study aimed to determine the association of change in NT-proBNP level with adverse outcomes a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinling Ma, Ang Li, Suyan Bian
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	BMC Geriatrics
Subjects:	NT-proBNP Elderly Type 2 myocardial infarction
Online Access:	https://doi.org/10.1186/s12877-025-06169-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)

NT-proBNP in Acute De Novo Heart Failure: A Key Biomarker for Predicting Myocardial Recovery—COMFE Registry
by: Raquel López-Vilella, et al.
Published: (2025-03-01)

Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels
by: Ruxandra Maria Christodorescu, et al.
Published: (2024-11-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)

Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)

Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure
by: Victor José Leal-Alcántara, et al.
Published: (2025-06-01)

Prevalence of periodontitis in chronic heart failure patients and its relationship with NT-ProBNP: A cross-sectional study
by: Sonika Sharma, et al.
Published: (2025-03-01)

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease
by: Jianping Liu, et al.
Published: (2025-04-01)

N- terminal pro brain natriuratic peptide (nt-probnp) in apparently healthy subjects compared to metabolic syndrome subjects
by: Zaidan Azeez Hasan, et al.
Published: (2022-06-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
by: Yuancheng Zhao, et al.
Published: (2023-12-01)

Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis
by: Noelia Costa-Rodríguez, et al.
Published: (2025-07-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies
by: Cuncun Chen, et al.
Published: (2024-12-01)

Diagnostic Efficacy of Combined N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) Testing in Myocardial Injury of Children with Mycoplasma Pneumoniae Pneumonia
by: Yang M, et al.
Published: (2025-06-01)

Role of NT-proBNP and Myeloperoxidase as Predictors of Abnormal Stress Test Results and Revascularization in Intermediate-Risk NSTE-ACS: A Prospective Study
by: Enrique Soltero-Mariscal, et al.
Published: (2025-02-01)

THE LEVEL OF CARDIAC PEPTIDE NT-PROBNP INCREASES DURING PRE-ECLAMPSIA OF PREGNANT WOMEN
by: Н. Русой, et al.
Published: (2025-04-01)

Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF
by: Robert Shaddy, et al.
Published: (2025-08-01)

Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
by: Ahmet Celik, et al.
Published: (2025-08-01)

The addition of alpha-ketoglutarate to NT-proBNP improves the prediction of long-term all-cause mortality in acute heart failure patients
by: Tianyu Xu, et al.
Published: (2025-12-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Troponin, NT-proBNP and postoperative atrial fibrillation in a prospective cohort undergoing coronary artery bypass surgery
by: Amelie H. Ohlrogge, et al.
Published: (2025-08-01)

Risk prediction in acute coronary syndrome depending on the types of myocard revascularization
by: R. V. Denina
Published: (2016-12-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction
by: Yoichiro Otaki, et al.
Published: (2025-04-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Machine learning integration of multimodal data identifies key features of circulating NT-proBNP in people without cardiovascular diseases
by: Zhiyuan Ning, et al.
Published: (2025-04-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study [Corrigendum]
by: Liu R, et al.
Published: (2025-03-01)

Navigating the challenges of NT-proBNP result disclosure in clinical research
by: Denise A. Kent, et al.
Published: (2025-01-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Elevation of Cardiac Biomarkers in COVID-19 As a Major Determinant for Mortality: A Systematic Review
by: Tracy Anabella Hermansyah, et al.
Published: (2022-01-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department
by: Antonios Diakantonis, et al.
Published: (2024-12-01)

Minimizing unnecessary proBNP blood tests: an evaluation of a pop-up form implementation in general practice
by: Morvarid Sophia Esmaeilzadeh, et al.
Published: (2025-01-01)

N-terminal pro-B-type natriuretic peptide as a predictive marker of the outcomes of fibrinolytic therapy in acute ST-elevation myocardial infarction
by: Amit Kumar, et al.
Published: (2024-04-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)